ARVIND RAGHAVAN, Ph.D.
Dr. Raghavan has broad experience in the preclinical and clinical development of small molecule therapeutics, biologicals, and imaging agents for CNS disorders, metabolic diseases and oncology indications. His expertise encompasses design and execution of preclinical safety and efficacy studies, fund-raising strategies, and the management of strategic partnerships with biotech and pharmaceutical companies. His extensive research experience covers various aspects of immune cell and oncogene activation, receptor pharmacology and small animal disease models.
Director of R&D, Tansna Therapeutics
Director of R&D, Tychon Biosciences
Director of R&D, Diamedica
Sr. Research Fellow, Mayo Clinic, Rochester
Research Associate, University of Minnesota
PhD in Molecular Biology, from Jawaharlal Nehru University, India